Despite its advantages, targeted therapy is not without challenges. One issue is the development of resistance to targeted drugs, which can occur when cancer cells mutate and find alternative pathways to grow and survive. Additionally, not all tumors have identifiable targets, limiting the use of these therapies. Histological analysis is crucial for identifying potential targets and monitoring for resistance.
